1
|
Guillaume-Jugnot P, Shor N, Bielle F, Zavanone C, Barete S, Maillart E. Atypical multiple sclerosis associated with indolent systemic mastocytosis treated by cladribine. Rev Neurol (Paris) 2023; 179:925-927. [PMID: 37500352 DOI: 10.1016/j.neurol.2023.03.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2022] [Revised: 12/14/2022] [Accepted: 03/11/2023] [Indexed: 07/29/2023]
Affiliation(s)
- P Guillaume-Jugnot
- Department of Internal Medicine and Clinical Immunology, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France.
| | - N Shor
- Department of Neuroradiology, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France
| | - F Bielle
- Department of Neuropathology, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France; Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la Moelle épinière (ICM), Sorbonne Université, Paris, France
| | - C Zavanone
- Department of Neurology, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France
| | - S Barete
- Unit of Dermatology, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France; Reference center for mastocytosis (CEREMAST), Hôpital Pitié-Salpêtrière, Paris, France
| | - E Maillart
- Department of Neurology, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France
| |
Collapse
|
2
|
Matcaşu I, Haddad N, Barrou B, Conti F, Barete S. Biotherapies for chronic inflammatory dermatosis in organ transplant recipients: 3 case reports and a literature review. Ann Dermatol Venereol 2023; 150:219-222. [PMID: 36739220 DOI: 10.1016/j.annder.2022.11.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2022] [Revised: 07/27/2022] [Accepted: 11/08/2022] [Indexed: 02/05/2023]
Affiliation(s)
- I Matcaşu
- Dermatology Unit, Pitié-Salpêtrière Hospital, APHP, Sorbonne Université, Paris, France
| | - N Haddad
- Dermatology Unit, Pitié-Salpêtrière Hospital, APHP, Sorbonne Université, Paris, France
| | - B Barrou
- Kidney Transplantation Unit, Pitié-Salpêtrière Hospital, APHP, Sorbonne Université, Paris, France
| | - F Conti
- Liver Transplantation Unit, Pitié-Salpêtrière Hospital, APHP, Sorbonne Université, Paris, France
| | - S Barete
- Dermatology Unit, Pitié-Salpêtrière Hospital, APHP, Sorbonne Université, Paris, France.
| |
Collapse
|
3
|
Comarmond C, Leroux G, Frances C, Barete S, Saadoun D, Cacoub P. [Cutaneous hyperpigmentation, flexion of interphalangeal joints and hallux valgus in a 42 year-old patient]. Rev Med Interne 2022; 43:452-454. [PMID: 35811111 DOI: 10.1016/j.revmed.2022.05.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2022] [Revised: 05/25/2022] [Accepted: 05/27/2022] [Indexed: 11/28/2022]
Affiliation(s)
- C Comarmond
- Department of Internal Medicine and Clinical Immunology, Lariboisière Hospital, Université Paris Cité, 75010 Paris, France.
| | - G Leroux
- Department of Internal Medicine and Clinical Immunology, Pitié-Salpêtrière Hospital, Sorbonne Université, 75013 Paris, France
| | - C Frances
- Department of Internal Medicine and Clinical Immunology, Pitié-Salpêtrière Hospital, Sorbonne Université, 75013 Paris, France
| | - S Barete
- Dermatology, Pitié-Salpêtrière Hospital, Sorbonne Université, 75013 Paris, France
| | - D Saadoun
- Department of Internal Medicine and Clinical Immunology, Pitié-Salpêtrière Hospital, Sorbonne Université, 75013 Paris, France
| | - P Cacoub
- Department of Internal Medicine and Clinical Immunology, Pitié-Salpêtrière Hospital, Sorbonne Université, 75013 Paris, France
| |
Collapse
|
4
|
Dobos G, de Masson A, Ram-Wolff C, Beylot-Barry M, Pham-Ledard A, Ortonne N, Oro S, Battistella M, d’Incan M, Rouanet J, Franck F, Vignon-Pennamen MD, Franck N, Carlotti A, Boulinguez S, Lamant L, Petrella T, Dalac S, Joly P, Courville P, Rivet J, Dereur O, Amatore F, Taix S, Grange F, Durlach A, Quéreux G, Josselin N, Moulonguet I, Mortier L, Dubois R, Maubec E, Laroche L, Michel L, Templier I, Barete S, Nardin C, Augereau O, Vergier B, Bagot M. Changements dans l’épidémiologie des lymphomes cutanés primitifs en France : une analyse de 8593 patients du registre du Groupe Français d’Etude des Lymphomes Cutanés (GFELC). Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.141] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
5
|
Bugaut H, Maillard H, Jacobzone C, Le Pelletier F, Charlotte F, Arock M, Dubreuil P, Bulai Livideanu C, Hermine O, Barete S. La cladribine améliore les manifestations cutanées, la qualité de vie dermatologique et spécifique des patients adultes avec mastocytose : étude rétrospective de 16 patients du CEREMAST. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
6
|
Zuelgaray E, Chevret S, Jachiet M, Cacoub P, Chasset F, Barete S, Frances C, Cordoliani F, Pallure V, Brenaut E, Kahn JE, Bessis D, Bagot M, Sène D, Bouaziz JD. L’atteinte du tronc et la peau d’orange sont des facteurs de mauvais pronostic dans la fasciite à éosinophiles : une étude de cohorte multicentrique rétrospective de 119 patients. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
7
|
Dobos G, de Masson A, Ram-Wolff C, Beylot-Barry M, Pham-Ledard A, Ortonne N, Ingen-Housz-Oro S, Battistella M, d'Incan M, Rouanet J, Franck F, Vignon-Pennamen MD, Franck N, Carlotti A, Boulinguez S, Lamant L, Petrella T, Dalac S, Joly P, Courville P, Rivet J, Dereure O, Amatore F, Taix S, Grange F, Durlach A, Quéreux G, Josselin N, Moulonguet I, Mortier L, Dubois R, Maubec E, Laroche L, Michel L, Templier I, Barete S, Nardin C, Augereau O, Vergier B, Bagot M. Epidemiological changes in cutaneous lymphomas: an analysis of 8593 patients from the French Cutaneous Lymphoma Registry. Br J Dermatol 2020; 184:1059-1067. [PMID: 33131055 DOI: 10.1111/bjd.19644] [Citation(s) in RCA: 34] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/28/2020] [Indexed: 12/16/2022]
Abstract
BACKGROUND Primary cutaneous lymphomas (PCLs) are a heterogeneous group of T-cell (CTCL) and B-cell (CBCL) malignancies. Little is known about their epidemiology at initial presentation in Europe and about potential changes over time. OBJECTIVES The aim of this retrospective study was to analyse the frequency of PCLs in the French Cutaneous Lymphoma Registry (GFELC) and to describe the demography of patients. METHODS Patients with a centrally validated diagnosis of primary PCL, diagnosed between 2005 and 2019, were included. RESULTS The calculated incidence was unprecedently high at 1·06 per 100 000 person-years. The number of included patients increased yearly. Most PCL subtypes were more frequent in male patients, diagnosed at a median age of 60 years. The relative frequency of rare CTCL remained stable, the proportion of classical mycosis fungoides (MF) decreased, and the frequency of its variants (e.g. folliculotropic MF) increased. Similar patterns were observed for CBCL; for example, the proportion of marginal-zone CBCL increased over time. CONCLUSIONS Changes in PCL frequencies may be explained by the emergence of new diagnostic criteria and better description of the entities in the most recent PCL classification. Moreover, we propose that an algorithm should be developed to confirm the diagnosis of PCL by central validation of the cases.
Collapse
Affiliation(s)
- G Dobos
- Dermatology Department, Saint-Louis Hospital, AP-HP, Paris, France.,INSERM U976, Human Immunology Pathophysiology and Immune Therapies, Paris, France.,Université de Paris, Paris, France
| | - A de Masson
- Dermatology Department, Saint-Louis Hospital, AP-HP, Paris, France.,INSERM U976, Human Immunology Pathophysiology and Immune Therapies, Paris, France.,Université de Paris, Paris, France
| | - C Ram-Wolff
- Dermatology Department, Saint-Louis Hospital, AP-HP, Paris, France.,INSERM U976, Human Immunology Pathophysiology and Immune Therapies, Paris, France.,Université de Paris, Paris, France
| | - M Beylot-Barry
- Dermatology Department, Université de Bordeaux, Bordeaux, France
| | - A Pham-Ledard
- Dermatology Department, Université de Bordeaux, Bordeaux, France
| | - N Ortonne
- Pathology Department, Henri Mondor Hospital, INSERM U955, Université Paris Est, AP-HP, Paris, France
| | - S Ingen-Housz-Oro
- Dermatology Department, Henri Mondor Hospital, INSERM U955, Université Paris Est, AP-HP, Paris, France
| | - M Battistella
- INSERM U976, Human Immunology Pathophysiology and Immune Therapies, Paris, France.,Université de Paris, Paris, France.,Pathology Department, Saint-Louis Hospital, AP-HP, Paris, France
| | - M d'Incan
- Dermatology and Cutaneous Oncology, Estaing University Hospital, Université de Clermont-Ferrand, Clermont-Ferrand, France
| | - J Rouanet
- Pathology Department, NHE Clermont et SIPATH UNILABS, Clermont-Ferrand, France
| | - F Franck
- Pathology Department, NHE Clermont et SIPATH UNILABS, Clermont-Ferrand, France
| | | | - N Franck
- Dermatology Department, Cochin Hospital, AP-HP, Paris, France
| | - A Carlotti
- Pathology Department, Cochin Hospital, AP-HP, Paris, France
| | - S Boulinguez
- Dermatology Department, Cahors Hospital, Toulouse, France
| | - L Lamant
- Pathology and Cytopathology Department, Institut Universitaire du Cancer Toulouse, Toulouse, France
| | - T Petrella
- Pathology Department, Dijon Bourgogne University Hospital, Dijon, France
| | - S Dalac
- Dermatology Department, Dijon Bourgogne University Hospital, Dijon, France
| | - P Joly
- Dermatology Department, Rouen University Hospital, INSERM U1234, Rouen Institute for Research and Innovation in Biomedicine, Rouen, France
| | - P Courville
- Pathology Department, Rouen University Hospital, INSERM U1234, Rouen Institute for Research and Innovation in Biomedicine, Rouen, France
| | - J Rivet
- Dermatology Department, Université de Bordeaux, Bordeaux, France.,Pathology Department, Henri Mondor Hospital, INSERM U955, Université Paris Est, AP-HP, Paris, France
| | - O Dereure
- Dermatology Department, Montpellier University Hospital, Montpellier, France
| | - F Amatore
- Department of Dermatology and Oncodermatology, Aix-Marseille University, AP-HM, Timone Hospital, Marseille, France
| | - S Taix
- Department of Pathology, Aix-Marseille University, AP-HM, Timone Hospital, Marseille, France
| | - F Grange
- Dermatology Department, Robert Debré University Hospital, Reims, France
| | - A Durlach
- Pathology Department, Reims University Hospital, Reims, France
| | - G Quéreux
- Dermatology Department, Nantes University Hospital, Nantes, France
| | - N Josselin
- Pathology Department, Nantes University Hospital, Nantes, France
| | - I Moulonguet
- Dermatology Department, Saint-Louis Hospital, AP-HP, Paris, France
| | - L Mortier
- Dermatology Department, Claude Huriez University Hospital, INSERM U1189, Université de Lille, Lille, France
| | - R Dubois
- Pathology Department, Claude Huriez University Hospital, Lille, France
| | - E Maubec
- Dermatology Department, Avicenne Hospital, AP-HP, Paris, France
| | - L Laroche
- Dermatology Department, Avicenne Hospital, AP-HP, Paris, France
| | - L Michel
- INSERM U976, Human Immunology Pathophysiology and Immune Therapies, Paris, France.,Université de Paris, Paris, France
| | - I Templier
- Dermatology Department, Grenoble University Hospital, Grenoble, France
| | - S Barete
- Dermatology Department, Pité-Salpêtrière Hospital, AP-HP, Paris, France
| | - C Nardin
- Dermatology Department, Minjoz Hospital, Besancon, France, INSERM U1098, University of Franche Comté, EFS Bourgogne Franche-Comté and Franche-Comté University, Besançon, France
| | - O Augereau
- Pathology Department, Saint-André Hospital, Bordeaux University Hospital, INSERM U1053 - UMR BaRITOn, Eq 3 Oncogenèse des Lymphomes Cutanés, Université de Bordeaux, Bordeaux, France
| | - B Vergier
- Pathology Department, Saint-André Hospital, Bordeaux University Hospital, INSERM U1053 - UMR BaRITOn, Eq 3 Oncogenèse des Lymphomes Cutanés, Université de Bordeaux, Bordeaux, France
| | - M Bagot
- Dermatology Department, Saint-Louis Hospital, AP-HP, Paris, France.,INSERM U976, Human Immunology Pathophysiology and Immune Therapies, Paris, France.,Université de Paris, Paris, France
| | | |
Collapse
|
8
|
Bergeret B, Secco LP, Pallure V, Daien C, Pers YM, Gottlieb J, Barete S, Girard C, Lipsker D, Bessis D. Palmoplantar lichen planus-like lupus erythematosus keratoderma: an underrecognized and distinctive cutaneous manifestation of systemic or subacute lupus erythematosus. J Eur Acad Dermatol Venereol 2020; 35:e124-e126. [PMID: 32757396 DOI: 10.1111/jdv.16852] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2020] [Revised: 07/22/2020] [Accepted: 07/30/2020] [Indexed: 11/26/2022]
Affiliation(s)
- B Bergeret
- Department of Dermatology, Saint-Eloi Hospital, University Hospital of Montpellier, Montpellier, France
| | - L-P Secco
- Department of Dermatology, Saint-Eloi Hospital, University Hospital of Montpellier, Montpellier, France.,Department of Pathology, Gui de Chauliac Hospital, University Hospital of Montpellier, Montpellier, France
| | - V Pallure
- Department of Dermatology, Saint-Eloi Hospital, University Hospital of Montpellier, Montpellier, France.,Department of Dermatology and Internal Medicine, Perpignan Hospital, Perpignan, France
| | - C Daien
- Department of Rheumatology, Lapeyronie Hospital, University Hospital of Montpellier, Montpellier, France
| | - Y-M Pers
- Department of Rheumatology, Lapeyronie Hospital, University Hospital of Montpellier, Montpellier, France
| | - J Gottlieb
- Department of Internal Medicine, Bicètre University Hospital, AP-HP, Paris, France
| | - S Barete
- Department of Dermatology, La Pitié Salpétrière University Hospital, AP-HP, Paris, France
| | - C Girard
- Department of Dermatology, Saint-Eloi Hospital, University Hospital of Montpellier, Montpellier, France.,INSERM U1058, Montpellier, France
| | - D Lipsker
- Department of Dermatology, Civil Hospital, University Hospital of Strasbourg, Strasbourg, France
| | - D Bessis
- Department of Dermatology, Saint-Eloi Hospital, University Hospital of Montpellier, Montpellier, France.,INSERM U1058, Montpellier, France
| | | |
Collapse
|
9
|
Sonigo G, Battistella M, Beylot-Barry M, Oro S, Franck N, Barete S, Boulinguez S, Dereure O, Bonnet N, Socié G, Brice P, Boccara O, Bodemer C, Adamski H, D’Incan M, Ortonne N, Fraitag S, Brunet-Possenti F, Dalle S, Suarez F, Marcais A, Skowron F, Haidar D, Maubec E, Bohelay G, Laroche L, Mahé A, Birckel E, Bouaziz JD, Brocheriou I, Dubois R, Faiz S, Fadlallah J, Ram-Wolff C, Carlotti A, Bens G, Balme B, Vergier B, Laurent-Roussel S, Deschamps L, Carpentier O, Moguelet P, Hervé G, Comoz F, Le Gall F, Leverger G, Finon A, Augereau O, Bléchet C, Kerdraon R, lamant L, Tournier E, Franck F, Costes-Martineau V, Szablewski V, Taix S, Beschet I, Guérin F, Sepulveda F, Bagot M, De Saint-Basile G, Michonneau D, De Masson A. Étude clinique à long terme et mutations HAVCR2 chez 70 patients atteints de lymphome T sous cutané à type de panniculite. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.144] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
10
|
Barete S. Quoi de neuf en médecine interne ? Ann Dermatol Venereol 2019; 146:12S24-12S31. [DOI: 10.1016/s0151-9638(20)30103-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
11
|
Bergeret B, Lipsker D, Pallure V, Barete S, Gottlieb J, Durand L, Pers YM, Bessis D. Kératodermie palmo-plantaire livedoïde, une manifestation cutanée méconnue du lupus érythémateux systémique ou subaigu. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.059] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
12
|
Amoura A, Haroche J, Emile J, Barete S, Helias‐Rodzewicz Z, Charlotte F, Maisonobe T, Amoura Z, Cohen Aubart F. Sarcoidosis occurring during
BRAF
/
MEK
inhibitors is associated with paradoxical
ERK
activation in Erdheim‐Chester patients. J Eur Acad Dermatol Venereol 2019; 33:e348-e350. [DOI: 10.1111/jdv.15636] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- A. Amoura
- Service de Médecine Interne 2 Hôpital de la Pitié‐Salpêtrière Assistance Publique‐Hôpitaux de Paris Centre National de Référence Maladies Systémiques Rares, Lupus Systémique, Syndrome des Anticorps Antiphospholipides et Histiocytoses Sorbonne Université Paris France
| | - J. Haroche
- Service de Médecine Interne 2 Hôpital de la Pitié‐Salpêtrière Assistance Publique‐Hôpitaux de Paris Centre National de Référence Maladies Systémiques Rares, Lupus Systémique, Syndrome des Anticorps Antiphospholipides et Histiocytoses Sorbonne Université Paris France
| | - J.‐F. Emile
- Département de Pathologie EA4340 Hôpital Ambroise Paré Assistance Publique Hôpitaux de Paris Université Versailles‐Saint Quentin BoulogneFrance
| | - S. Barete
- Unité Fonctionnelle de Dermatologie Hôpital de la Pitié‐Salpêtrière Assistance Publique‐Hôpitaux de Paris Sorbonne Université Paris France
| | - Z. Helias‐Rodzewicz
- Département de Pathologie EA4340 Hôpital Ambroise Paré Assistance Publique Hôpitaux de Paris Université Versailles‐Saint Quentin BoulogneFrance
| | - F. Charlotte
- Service d'Anatomie Pathologique Hôpital de la Pitié‐Salpêtrière Assistance Publique‐Hôpitaux de Paris Sorbonne Université Paris France
| | - T. Maisonobe
- Département de Neurophysiologie Hôpital de la Pitié‐Salpêtrière Assistance Publique‐Hôpitaux de Paris Sorbonne Université Paris France
| | - Z. Amoura
- Service de Médecine Interne 2 Hôpital de la Pitié‐Salpêtrière Assistance Publique‐Hôpitaux de Paris Centre National de Référence Maladies Systémiques Rares, Lupus Systémique, Syndrome des Anticorps Antiphospholipides et Histiocytoses Sorbonne Université Paris France
| | - F. Cohen Aubart
- Service de Médecine Interne 2 Hôpital de la Pitié‐Salpêtrière Assistance Publique‐Hôpitaux de Paris Centre National de Référence Maladies Systémiques Rares, Lupus Systémique, Syndrome des Anticorps Antiphospholipides et Histiocytoses Sorbonne Université Paris France
| |
Collapse
|
13
|
Poirier E, Fraitag S, Tezenas du Montcel S, Moguelet P, Charlotte F, Lortholary O, Hermine O, Canioni D, Barete S. CD30 expression in cutaneous lesions of systemic mastocytosis: clinical, biological and histopathological analysis of 27 patients. J Eur Acad Dermatol Venereol 2019; 33:e344-e347. [DOI: 10.1111/jdv.15633] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Affiliation(s)
- E. Poirier
- Unité Fonctionnelle de Dermatologie Groupe Hospitalier Pitié‐Salpêtrière, AP‐HP UPMC Université Paris 06 Sorbonne Université Paris France
| | - S. Fraitag
- Centre National de Référence des Mastocytoses AP‐HP CEREMAST Paris France
- Service d'Anatomopathologie Hôpital Necker AP‐HP Université Paris‐Sorbonne Paris France
| | - S. Tezenas du Montcel
- UMR S 1136, INSERM U 1136 Institut Pierre Louis d’Épidémiologie et de Santé Publique UPMC Université Paris 06 Sorbonne Université Paris France
- Unité de Biostatistiques Groupe Hospitalier Pitié‐Salpêtrière AP‐HP Paris France
| | - P. Moguelet
- Service d'Anatomopathologie Hôpital Tenon, AP‐HP UPMC Université Paris 06 Sorbonne Universités Paris France
| | - F. Charlotte
- Service d'Anatomopathologie Groupe Hospitalier Pitié Salpêtrière, AP‐HP UPMC Université Paris 06 Sorbonne Université Paris France
| | - O. Lortholary
- Centre National de Référence des Mastocytoses AP‐HP CEREMAST Paris France
- Service d'Infectiologie Hôpital Necker AP‐HP Université Paris‐Sorbonne Paris France
| | - O. Hermine
- Centre National de Référence des Mastocytoses AP‐HP CEREMAST Paris France
- Service d'Hématologie Hôpital Necker AP‐HP Université Paris‐Sorbonne Paris France
| | - D. Canioni
- Centre National de Référence des Mastocytoses AP‐HP CEREMAST Paris France
- Service d'Anatomopathologie Hôpital Necker AP‐HP Université Paris‐Sorbonne Paris France
| | - S. Barete
- Unité Fonctionnelle de Dermatologie Groupe Hospitalier Pitié‐Salpêtrière, AP‐HP UPMC Université Paris 06 Sorbonne Université Paris France
- Centre National de Référence des Mastocytoses AP‐HP CEREMAST Paris France
| | | |
Collapse
|
14
|
Visseaux L, Durlach A, Barete S, Ingen‐Housz‐Oro S, Ortonne N, Grange F. Response to ‘Cutaneous eruptions associated with haematological malignancies: the need for a unifying nomenclature’. J Eur Acad Dermatol Venereol 2019; 33:e193. [DOI: 10.1111/jdv.15451] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- L. Visseaux
- Service d'Oncodermatologie Hôpital Robert Debré Reims France
| | - A. Durlach
- Service de Pathologie Hôpital Maison Blanche Reims France
| | - S. Barete
- Unité Fonctionnelle de Dermatologie Hôpital La Pitié Salpêtrière Paris France
| | | | - N. Ortonne
- Service de Pathologie Hôpital Henri Mondor Créteil France
| | - F. Grange
- Service d'Oncodermatologie Hôpital Robert Debré Reims France
| |
Collapse
|
15
|
Lombart F, Dillies A, Senet P, Pourchot D, Oro S, Modiano P, Barete S, Perceau G, Humbert P, Brault F, Poreaux C, Lorriaux A, Lok C, Chaby G. Calciphylaxie chez des patients non insuffisants rénaux : série de 10 cas. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.483] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
16
|
Zuelgaray E, Jachiet M, Barete S, Frances C, Cordoliani F, Cacoub P, Bagot M, Sène D, Bouaziz JD. Fasciite à éosinophiles : caractéristiques cliniques, histologiques, thérapeutiques et pronostiques à partir d’une série de 79 cas. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.488] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
17
|
Sonigo G, Battistella M, Beylot-Barry M, Oro S, Franck N, Barete S, Bouaziz J, Ram-Wolff C, Boulinguez S, Dereure O, Bachelez H, Bonnet N, Socie G, Brice P, Brunet-Possenti F, Dalle S, Suarez F, Marçais A, Boccara O, Bodemer C, Adamski H, D’Incan M, Fraitag S, Bagot M, Michonneau D, De Masson A. Lymphomes T sous-cutanés à type de panniculite : étude anatomoclinique rétrospective de 55 cas. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.074] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
18
|
Shourick J, Vesinet C, Monsel A, Le Pelletier F, Bories D, Barrou B, Nguyen S, Calmus Y, Lebrun-Vignes B, Barete S. GVH aiguë post-transplantation hépatique simulant une nécrolyse épidermique toxique. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.177] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
19
|
Cohen Aubart F, Haroche J, Emile JF, Charlotte F, Barete S, Schleinitz N, Donadieu J, Amoura Z. [Rosai-Dorfman disease: Diagnosis and therapeutic challenges]. Rev Med Interne 2018; 39:635-640. [PMID: 29501513 DOI: 10.1016/j.revmed.2018.02.011] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2017] [Revised: 01/28/2018] [Accepted: 02/04/2018] [Indexed: 12/24/2022]
Abstract
Rosai-Dorfman disease (RDD) was first described by the French pathologist Paul Destombes in 1965. It frequently affects children or young adults and is characterized by the presence of large histiocytes with emperipolesis. More than 50 years after this first description, the pathogenesis of this rare disease is still poorly understood. The revised classification of histiocytoses published in 2016 identified various forms of RDD, from familial RDD to IgG4-associated RDD. Almost 90% of the patients with RDD have cervical lymph nodes involvement although all the organs may virtually be involved. Outcomes are typically favorable. Treatments may be necessary in case of compression or obstruction, and are not well codified. The main therapeutic strategies rely on surgery, radiotherapy, steroids, immunosuppressive drugs or interferon-alpha and cladribine.
Collapse
Affiliation(s)
- F Cohen Aubart
- Service de médecine interne 2, centre national de référence maladies systémiques rares et histiocytoses, institut e3M, hôpital de la Pitié-Salpêtrière, AP-HP, 75013 Paris, France; Université Paris-VI, Sorbonnes-Universités, 75013 Paris, France.
| | - J Haroche
- Service de médecine interne 2, centre national de référence maladies systémiques rares et histiocytoses, institut e3M, hôpital de la Pitié-Salpêtrière, AP-HP, 75013 Paris, France; Université Paris-VI, Sorbonnes-Universités, 75013 Paris, France
| | - J-F Emile
- Département d'anatomo-pathologie, EA4340, hôpital Ambroise-Paré, université de Versailles, AP-HP, 92104 Boulogne, France
| | - F Charlotte
- Université Paris-VI, Sorbonnes-Universités, 75013 Paris, France; Service d'anatomo-pathologie, hôpital de la Pitié-Salpêtrière, AP-HP, 75013 Paris, France
| | - S Barete
- UF de dermatologie, hôpital de la Pitié-Salpêtrière, AP-HP, 75013 Paris, France
| | - N Schleinitz
- Service de médecine interne, hôpital de la Timone et Aix-Marseille université, AP-HM, 13385 Marseille, France
| | - J Donadieu
- Service d'hématologie, hôpital Trousseau, AP-HP, 75012 Paris, France
| | - Z Amoura
- Service de médecine interne 2, centre national de référence maladies systémiques rares et histiocytoses, institut e3M, hôpital de la Pitié-Salpêtrière, AP-HP, 75013 Paris, France; Université Paris-VI, Sorbonnes-Universités, 75013 Paris, France
| |
Collapse
|
20
|
Visseaux L, Durlach A, Barete S, Beylot-Barry M, Bonnet N, Chassine A, Franck N, Herve G, Leclec'h C, Machet L, Ingen-Housz-Oro S, Petrella T, Vergier B, Ortonne N, Grange F. T-cell papulosis associated with B-cell malignancy: a distinctive clinicopathologic entity. J Eur Acad Dermatol Venereol 2018; 32:1469-1475. [DOI: 10.1111/jdv.14805] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2017] [Accepted: 01/03/2018] [Indexed: 10/18/2022]
Affiliation(s)
- L. Visseaux
- Service de Dermatologie; Hôpital Robert Debré; Reims France
| | - A. Durlach
- Laboratoire Pol Bouin; Hôpital Maison Blanche; Reims France
| | - S. Barete
- Service de Dermatologie; Hôpital Pitié-Salpêtrière; Paris France
| | - M. Beylot-Barry
- Service de Dermatologie; Hôpital Saint-André; Bordeaux France
| | - N. Bonnet
- Dermatologie; Institut Paoli Calmettes; Marseille France
| | | | - N. Franck
- Service de Dermatologie; Hôpital Cochin; Paris France
| | - G. Herve
- Service de Pathologie; Hôpital Pitié-Salpêtrière; Paris France
| | - C. Leclec'h
- Service de Dermatologie; CHU d'Angers; Angers France
| | - L. Machet
- Service de Dermatologie; Hôpital Trousseau; Tours France
| | | | - T. Petrella
- Department of Hematology-Oncology; University of Montréal; Montréal Canada
| | - B. Vergier
- Service de Pathologie; Hôpital Haut-Levêque; Pessac France
| | - N. Ortonne
- Service de Pathologie; Hôpital Henri Mondor; Créteil France
| | - F. Grange
- Service de Dermatologie; Hôpital Robert Debré; Reims France
| |
Collapse
|
21
|
Galezowski A, Deylon J, Le Cleach L, Guegan S, Ducroux E, Alanio A, Moguelet P, Dadban A, Leccia M, Le Pelletier F, Francès C, Lebbé C, Barete S. Mycoses cutanées profondes des transplantés d’organes solides : étude observationnelle multicentrique pour le groupe peau et greffe d’organe (GPGO). Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
22
|
Visseaux L, Durlach A, Barete S, Bayaram M, Beylot-Barry M, Bonnet N, Chassine A, Combemale P, Dhaille F, Franck N, Hervé G, Leclec’h C, Machet L, Oro S, Petrella T, Vergier B, Ortonne N, Grange F. Papulose T associée aux hémopathies B. Ann Dermatol Venereol 2016. [DOI: 10.1016/j.annder.2016.09.165] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
23
|
Fargeas C, Scalbert C, Adamski H, Avenel-Audran M, Aubin F, Barete S, Schmutz JL, Mahe E. Photoprotection et transplantation rénale… 10 ans après. Ann Dermatol Venereol 2016. [DOI: 10.1016/j.annder.2016.09.256] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
24
|
Ducroux E, Euvrard S, Decullier E, Barete S, Beylot-Barry M, Joly P, Leccia MT, Richard MA, Kanitakis J, Sebbag L. Efficacité de l’évérolimus dans la prévention secondaire des cancers cutanés chez les greffés cardiaques. Ann Dermatol Venereol 2016. [DOI: 10.1016/j.annder.2016.09.218] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
25
|
Zumelzu C, Vesvrotte CRD, Brechignac S, Levy A, Guyot A, Frances C, Laroche L, Barete S, Caux F. Localisation cutanée de maladie de Hodgkin : à propos de 2 cas dont une présentation pustuleuse originale. Ann Dermatol Venereol 2016. [DOI: 10.1016/j.annder.2016.09.541] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
26
|
Mermin D, Bonnet N, Bouabdallah R, Duval-Modeste AB, Mortier L, Oro S, Ram-Wolff C, Barete S, Dalle S, Maubec E, Quereux G, Templier I, Bagot M, Grange F, Vergier B, Merlio JP, Pham-Ledard A, Dousseau A, Maillard A, Beylot-Barry M. Lenalidomide dans les lymphomes cutanés primitifs B diffus à grandes cellules type-jambe en rechute ou réfractaires : PHRC REV-LEG. Ann Dermatol Venereol 2016. [DOI: 10.1016/j.annder.2016.09.172] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
27
|
Lortholary O, Chandesris MO, Bulai Livideanu C, Paul C, Guillet G, Jassem E, Niedoszytko M, Barete S, Verstovsek S, Damaj G, Canioni D, Fraitag S, Lhermitte L, Georgin-Lavialle S, Afrin L, Hanssens K, Agopian J, Kinet JP, Auclair C, Mansfield C, Moussy A, Dubreuil P, Hermine O. Masitinib dans le traitement de la mastocytose systemique sévère de forme indolente ou latente : un essai clinique de phase 3 randomisé et controllé. Ann Dermatol Venereol 2016. [DOI: 10.1016/j.annder.2016.09.227] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
28
|
Abstract
The objective of this study was to observe the clinical and pathologic features of digital lesions in a cohort of 50 patients with systemic lupus erythematosus (SLE). Biopsy and pictures of digital lesions were performed in 50 consecutive patients with SLE and digital lesions. A clinical diagnosis of vasculitis was previously suggested in 36% of cases. Pictures were reviewed by three dermatologists and all the tissue sections were analysed by the same pathologist. Files of patients were reviewed retrospectively. Activity of SLE was established according to the lupus activity index (LAI). Digital lesions in SLE were frequently painful (60%) with a finger-pulp inflammation (70%). According to clinical and pathological correlation, five patients had acute cutaneous lupus, five subacute cutaneous lupus, 21 discoid lupus and 15 chilblain lupus. Two patients presented vasculitis: one had an urticarial vasculitis concomitantly to a lupus flare, the other had an erythema elevatum diutinum, independent of SLE evolution. Thrombosis of dermal vessels was present in two patients with SLE-associated antiphospholipid syndrome and in two patients with chilblain lupus. LAI was > 1.5 in only seven patients. These results highlight the tendency to clinically overestimate the prevalence of cutaneous vasculitis of the fingers in patients without active SLE. Clinical features of cutaneous lupus of the digits are polymorphous. So, a pathological examination of the lesions is often necessary for diagnosis and proper management.
Collapse
Affiliation(s)
- J D Bouaziz
- Department of Dermatology, Hôpital Tenon, Paris, France
| | | | | | | | | | | |
Collapse
|
29
|
Gardette E, Moguelet P, Barete S, Frances C, Senet P. [Unusual course of CD8+ epidermotropic cutaneous T-cell lymphoma]. Ann Dermatol Venereol 2016; 143:846-851. [PMID: 27161647 DOI: 10.1016/j.annder.2016.03.022] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2015] [Revised: 02/12/2016] [Accepted: 03/10/2016] [Indexed: 12/22/2022]
Abstract
BACKGROUND Aggressive epidermotropic cutaneous T-cell lymphoma (AECL) is a rare and aggressive form of lymphoma that exhibits systemic spread within a few months that is not preceded by any indolent form. Herein, we report a case of AECL occurring on foot lesions present for six years, and initially diagnosed as Woringer-Kolopp disease, or pagetoid cutaneous T-cell lymphoma. PATIENTS AND METHODS A male patient presented an ulcerated lesion of the ankle that had been present for six years. Biopsy revealed pagetoid migration of CD8+, CD2-, CD5-, CD7+, CD30- and CD56- lymphocytes with expression of cytotoxic markers and of Ki67 in over 60% of cells. The resulting diagnosis was one of pagetoid cutaneous T-cell lymphoma, also known as Woringer-Kolopp disease. Despite treatment with methotrexate and carmustine, the ulcer worsened rapidly within two months. Subsequent biopsy revealed epidermal and dermal infiltration with large cells of identical phenotype to that seen in the previous biopsy, with angiocentrism and expression of Ki67 in over 90% of cells, pointing to a diagnosis of AECL. Progression to disseminated ulceronecrotic lesions occurred rapidly, and the patient died of sepsis within a few months. DISCUSSION AECL is characterised by ulcerative-haemorrhagic lesions that develop aggressively without any preceding mild cutaneous lesions. Median survival is 12 months. Histological analysis shows pagetoid epidermotropism comprising large monomorphic CD8+, CD2- and CD5- cells with markers for cytotoxicity and high expression of Ki67. The initial indolent phase in the case we report herein accounts for the diagnostic confusion at the outset with Woringer-Kolopp disease. Negative status of CD2 and CD5 labels may allow prompt diagnosis of AECL.
Collapse
Affiliation(s)
- E Gardette
- Service de dermatologie et d'allergologie, hôpital Tenon, AP-HP, 4, rue de la Chine, 75970 Paris cedex 20, France.
| | - P Moguelet
- Service d'anatomopathologie, hôpital Tenon, AP-HP, 4, rue de la Chine, 75970 Paris cedex 20, France
| | - S Barete
- Service de dermatologie, groupe hospitalier Pitié-Salpétrière, AP-HP, 47-83, boulevard de l'hôpital, 75013 Paris, France
| | - C Frances
- Service de dermatologie et d'allergologie, hôpital Tenon, AP-HP, 4, rue de la Chine, 75970 Paris cedex 20, France
| | - P Senet
- Service de dermatologie et d'allergologie, hôpital Tenon, AP-HP, 4, rue de la Chine, 75970 Paris cedex 20, France
| |
Collapse
|
30
|
Ratour-Bigot C, Milpied B, Yazdanpanah Y, Barete S, Vuong V, Descamps V. Étude rétrospective de 17 cas de DRESS chez des patients infectés par le VIH : DRESS ou VRESS ? Ann Dermatol Venereol 2015. [DOI: 10.1016/j.annder.2015.10.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
31
|
Hurabielle C, Ingen-Housz-Oro S, Ortonne N, Cornillet-Lefèbvre P, Merah A, D'Incan M, Joly P, Franck N, Estève E, Maubec E, Grange F, Machet L, Laroche L, Barete S, Dalac S, Mortier L, Michel C, Quereux G, Saiag P, Ram-Wolff C, Lenormand B, Wechsler J, Bastuji-Garin S, Bagot M, Delfau-Larue M. Frequency and prognostic value of cutaneous molecular residual disease in mycosis fungoides: a prospective multicentre trial of the Cutaneous Lymphoma French Study Group. Br J Dermatol 2015; 173:1015-23. [DOI: 10.1111/bjd.14017] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/29/2015] [Indexed: 11/27/2022]
|
32
|
Mitr R, Barete S, Fraitag S, Da Maia E, Lepelletier F, Le Naour G, Looten V, Capron F. Mastocytoses systémiques : biopsies cutanées, évaluation par la pathologie digitale. Ann Pathol 2015. [DOI: 10.1016/j.annpat.2015.08.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
33
|
Hamelin A, Vial-Dupuy A, Lebrun-Vignes B, Francès C, Soria A, Barete S. [Acute blue urticaria following subcutaneous injection of patent blue dye]. Ann Dermatol Venereol 2015; 142:670-4. [PMID: 26372548 DOI: 10.1016/j.annder.2015.08.008] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2015] [Revised: 04/15/2015] [Accepted: 08/05/2015] [Indexed: 11/18/2022]
Abstract
BACKGROUND Patent blue (PB) is a lymphatic vessel dye commonly used in France for sentinel lymph node detection in breast cancer, and less frequently in melanoma, and which may induce hypersensitivity reactions. We report a case of acute blue urticaria occurring within minutes of PB injection. PATIENTS AND METHODS Ten minutes after PB injection for sentinel lymph node detection during breast cancer surgery, a 49-year-old woman developed generalised acute blue urticaria and eyelid angioedema without bronchospasm or haemodynamic disturbance, but requiring discontinuation of surgery. Skin testing using PB and the anaesthetics given were run 6 weeks after the episode and confirmed PB allergy. PB was formally contra-indicated. DISCUSSION Immediate hypersensitivity reactions to PB have been reported for between 0.24 and 2.2% of procedures. Such reactions are on occasion severe, chiefly involving anaphylactic shock. Two mechanisms are probably associated: non-specific histamine release and/or an IgE-mediated mechanism. Skin tests are helpful in confirming the diagnosis of PB allergy. CONCLUSION Blue acute urticaria is one of the clinical manifestations of immediate hypersensitivity reactions to patent blue dye. Skin tests must be performed 6 weeks after the reaction in order to confirm the diagnosis and formally contra-indicate this substance.
Collapse
Affiliation(s)
- A Hamelin
- Service de dermatologie-allergologie, hôpital Tenon, AP-HP, 4, rue de la Chine, 75020 Paris, France.
| | - A Vial-Dupuy
- Service de dermatologie-allergologie, hôpital Tenon, AP-HP, 4, rue de la Chine, 75020 Paris, France
| | - B Lebrun-Vignes
- Centre de pharmacovigilance, groupe hospitalier Pitié-Salpêtrière, 47-83, boulevard de l'Hôpital, 75013 Paris, France
| | - C Francès
- Service de dermatologie-allergologie, hôpital Tenon, AP-HP, 4, rue de la Chine, 75020 Paris, France; Sorbonne universités, UPMC université Paris 6, 4, place Jussieu, 75005 Paris, France
| | - A Soria
- Service de dermatologie-allergologie, hôpital Tenon, AP-HP, 4, rue de la Chine, 75020 Paris, France; Sorbonne universités, UPMC université Paris 6, 4, place Jussieu, 75005 Paris, France; Unité mixte de recherche de santé (UMRS) CR7, centre d'immunologie et des maladies infectieuses-Paris (Cimi-Paris), 75013 Paris, France; Institut national de santé et de recherche médicale (Inserm) U1135, Cimi-Paris, 75013 Paris, France
| | - S Barete
- Service de dermatologie-allergologie, hôpital Tenon, AP-HP, 4, rue de la Chine, 75020 Paris, France; Sorbonne universités, UPMC université Paris 6, 4, place Jussieu, 75005 Paris, France; Unité fonctionnelle de dermatologie, groupe hospitalier Pitié-Salpêtrière, AP-HP, 47-83, boulevard de l'Hôpital, 75013 Paris, France
| |
Collapse
|
34
|
Monfort JB, Lebrun-Vignes B, Nguyen S, Francès C, Souchet L, Vernant JP, Le Pelletier F, Leblond V, Barete S. La maladie aiguë du greffon contre l’hôte (GVH) de type Lyell : description d’une cohorte de patients et comparaison historique clinique, biologique, et pharmacologique. Ann Dermatol Venereol 2014. [DOI: 10.1016/j.annder.2014.09.116] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
35
|
Hurabielle C, Oro S, Merah A, D’Incan M, Joly P, Franck N, Estève E, Maubec E, Grange F, Machet L, Laroche L, Barete S, Dalac S, Mortier L, Michel C, Quereux G, Saiag P, Ram-Wolff C, Cornillet-Lefebvre P, Lenormand B, Ortonne N, Wechsler J, Bagot M, Delfau-Larue MH. Fréquence et valeur pronostique de la maladie résiduelle dans le mycosis fongoïde. Ann Dermatol Venereol 2014. [DOI: 10.1016/j.annder.2014.09.359] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
36
|
Bohelay G, Rabaté C, Le Cleach L, Barete S, Euvrard S, Lebbé C, Francès C. Nouvelle transplantation rénale après maladie de Kaposi du transplanté. Ann Dermatol Venereol 2014. [DOI: 10.1016/j.annder.2014.09.139] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
37
|
Chasset F, Barete S, Arnaud L, Le pelletier F, Charlotte F, Emile JF, Amoura Z, Francès C, Haroche J. Manifestations dermatologiques de la maladie d’Erdheim-Chester. Ann Dermatol Venereol 2014. [DOI: 10.1016/j.annder.2014.09.126] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
38
|
Barete S. Les mastocytoses. Réponses au pré-test. Ann Dermatol Venereol 2014. [DOI: 10.1016/j.annder.2014.09.026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
39
|
|
40
|
Jachiet M, de Masson A, Peffault de Latour R, Rybojad M, Robin M, Bourhis JH, Xhaard A, Dhedin N, Sicre de Fontbrune F, Suarez F, Barete S, Parquet N, Nguyen S, Ades L, Rubio MT, Wittnebel S, Bagot M, Socié G, Bouaziz JD. Skin ulcers related to chronic graft-versus-host disease: clinical findings and associated morbidity. Br J Dermatol 2014; 171:63-8. [DOI: 10.1111/bjd.12828] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/06/2014] [Indexed: 11/29/2022]
Affiliation(s)
- M. Jachiet
- Department of Dermatology; AP-HP; Université Paris VII Sorbonne Paris Cité; and Hôpital Saint Louis; Paris France
| | - A. de Masson
- Department of Dermatology; AP-HP; Université Paris VII Sorbonne Paris Cité; and Hôpital Saint Louis; Paris France
| | - R. Peffault de Latour
- Department of Haematology; AP-HP; Université Paris VII Sorbonne Paris Cité; and Hôpital Saint Louis; Paris France
| | - M. Rybojad
- Department of Dermatology; AP-HP; Université Paris VII Sorbonne Paris Cité; and Hôpital Saint Louis; Paris France
| | - M. Robin
- Department of Haematology; AP-HP; Université Paris VII Sorbonne Paris Cité; and Hôpital Saint Louis; Paris France
| | - J.-H. Bourhis
- Department of Haematology; AP-HP; Institut Gustave Roussy; Villejuif France
| | - A. Xhaard
- Department of Haematology; AP-HP; Université Paris VII Sorbonne Paris Cité; and Hôpital Saint Louis; Paris France
| | - N. Dhedin
- Department of Haematology; AP-HP; Université Paris VII Sorbonne Paris Cité; and Hôpital Saint Louis; Paris France
| | - F. Sicre de Fontbrune
- Department of Haematology; AP-HP; Université Paris VII Sorbonne Paris Cité; and Hôpital Saint Louis; Paris France
| | - F. Suarez
- Department of Haematology; AP-HP; Hôpital Necker; Paris France
| | - S. Barete
- Department of Dermatology; AP-HP; Hôpital Pitié Salpêtrière; Paris France
| | - N. Parquet
- Department of Haematology; AP-HP; Université Paris VII Sorbonne Paris Cité; and Hôpital Saint Louis; Paris France
| | - S. Nguyen
- Department of Haematology; AP-HP; Hôpital Pitié Salpêtrière; Paris France
| | - L. Ades
- Departments of Haematology; AP-HP; Hôpital Avicenne; Bobigny France
| | - M.-T. Rubio
- Department of Haematology; AP-HP; Hôpital Saint Antoine; Paris France
| | - S. Wittnebel
- Department of Haematology; AP-HP; Institut Gustave Roussy; Villejuif France
| | - M. Bagot
- Department of Dermatology; AP-HP; Université Paris VII Sorbonne Paris Cité; and Hôpital Saint Louis; Paris France
| | - G. Socié
- Department of Haematology; AP-HP; Université Paris VII Sorbonne Paris Cité; and Hôpital Saint Louis; Paris France
| | - J.-D. Bouaziz
- Department of Dermatology; AP-HP; Université Paris VII Sorbonne Paris Cité; and Hôpital Saint Louis; Paris France
| |
Collapse
|
41
|
Julia F, Petrella T, Beylot-Barry M, Bagot M, Lipsker D, Machet L, Joly P, Dereure O, Wetterwald M, d'Incan M, Grange F, Cornillon J, Tertian G, Maubec E, Saiag P, Barete S, Templier I, Aubin F, Dalle S. Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients. Br J Dermatol 2014; 169:579-86. [PMID: 23646868 DOI: 10.1111/bjd.12412] [Citation(s) in RCA: 108] [Impact Index Per Article: 10.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/25/2013] [Indexed: 01/01/2023]
Abstract
BACKGROUND Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare disease characterized by malignant proliferation of a contingent blastic plasmacytoid dendritic cell. This rare entity is recognized mostly by cutaneous spreading, or not having a leukaemic component. The prognosis is very poor. OBJECTIVES To study a large cohort of 90 patients with BPDCN, to define additional symptoms to form a correct diagnosis earlier, and to manage such patients accordingly. METHODS We retrospectively reviewed BPDCN cases registered in the French Study Group on Cutaneous Lymphoma database between November 1995 and January 2012. Ninety patients were studied. Demographic data, clinical presentation, initial staging and outcome were recorded. RESULTS The group contained 62 male and 28 female patients (sex ratio 2·2). Their ages ranged from 8 to 103 years at the time of diagnosis (mean 67·2 years). Three major different clinical presentations were identified. Sixty-six patients (73%) presented with nodular lesions only, 11 patients (12%) with 'bruise-like' patches and 13 (14%) with disseminated lesions (patches and nodules). Mucosal lesions were seen in five patients (6%). The median survival in patients with BPDCN was 12 months. CONCLUSIONS We here distinguish three different clinical presentations of BPDCN. A nodular pattern is a more common feature than the originally reported 'bruise-like' pattern. Despite the fact that BPDCN may initially appear as a localized skin tumour, aggressive management including allogeneic bone marrow transplantation should be considered immediately, as it is currently the only option associated with long-term survival.
Collapse
Affiliation(s)
- F Julia
- Department of Dermatology, Cancer Research Center of Lyon, Claude Bernard Lyon 1 University, Hospices Civils de Lyon, Lyon, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
42
|
Lafont E, Sokol H, Sarre-Annweiler ME, Lecornet-Sokol E, Barete S, Hermine O, Pouchot J, Georgin-Lavialle S. Étiologies et orientation diagnostique devant un flush. Rev Med Interne 2014; 35:303-9. [DOI: 10.1016/j.revmed.2013.08.015] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2012] [Revised: 06/21/2013] [Accepted: 08/21/2013] [Indexed: 12/15/2022]
|
43
|
Jachiet M, de Masson A, Latour RPD, Bourhis JH, Robin M, Rybojad M, Xhaard A, Sicre de Fontbrune F, Suarez F, Barete S, Wittnebel S, Bagot M, Socié G, Bouaziz J. GVH cutanées chroniques ulcérées : spectre clinique et évolutif sur une cohorte rétrospective de 25 patients. Ann Dermatol Venereol 2013. [DOI: 10.1016/j.annder.2013.09.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
44
|
Allenbach Y, Leroux G, Uzuhnan Y, Valeyre D, Saadoun D, Aubart F, Hervier B, Hie M, Wipff J, Myiara M, Charuel J, Musset L, Audia S, Devillier H, Bonnote B, Barete S, Nimal N, Rigolet A, Herson S, Benveniste O. P.14.2 Dermatomyositis associated with MDA-5 antibodies: Report of the first European series. Neuromuscul Disord 2013. [DOI: 10.1016/j.nmd.2013.06.610] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
45
|
Seçkin D, Barete S, Euvrard S, Francès C, Kanitakis J, Geusau A, Del Marmol V, Harwood CA, Proby CM, Ali I, Güleç AT, Durukan E, Lebbé C, Alaibac M, Laffitte E, Cooper S, Bouwes Bavinck JN, Murphy GM, Ferrándiz C, Mørk C, Cetkovská P, Kempf W, Hofbauer GFL. Primary cutaneous posttransplant lymphoproliferative disorders in solid organ transplant recipients: a multicenter European case series. Am J Transplant 2013; 13:2146-53. [PMID: 23718915 DOI: 10.1111/ajt.12281] [Citation(s) in RCA: 57] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2012] [Revised: 03/30/2013] [Accepted: 04/08/2013] [Indexed: 01/25/2023]
Abstract
Primary cutaneous posttransplant lymphoproliferative disorders (PTLD) are rare. This retrospective, multicenter study of 35 cases aimed to better describe this entity. Cases were (re)-classified according to the WHO-EORTC or the WHO 2008 classifications of lymphomas. Median interval between first transplantation and diagnosis was 85 months. Fifty-seven percent of patients had a kidney transplant. Twenty-four cases (68.6%) were classified as primary cutaneous T cell lymphoma (CTCL) and 11 (31.4%) as primary cutaneous B cell PTLD. Mycosis fungoides (MF) was the most common (50%) CTCL subtype. Ten (90.9%) cutaneous B cell PTLD cases were classified as EBV-associated B cell lymphoproliferations (including one plasmablastic lymphoma and one lymphomatoid granulomatosis) and one as diffuse large B cell lymphoma, other, that was EBV-negative. Sixteen (45.7%) patients died after a median follow-up of 19.5 months (11 [68.8%] with CTCL [6 of whom had CD30(+) lymphoproliferative disorders (LPD)] and 5 [31.2%] with cutaneous B cell PTLD. Median survival times for all patients, CTCL and cutaneous B cell PTLD subgroups were 93, 93, and 112 months, respectively. Survival rates for MF were higher than those for CD30(+) LPD. The spectrum of primary CTCL in organ transplant recipients (OTR) is similar to that in the general population. The prognosis of posttransplant primary cutaneous CD30(+) LPD is worse than posttransplant MF and than its counterpart in the immunocompetent population. EBV-associated cutaneous B cell LPD predominates in OTR.
Collapse
Affiliation(s)
- D Seçkin
- Department of Dermatology, Başkent University Faculty of Medicine, Ankara, Turkey.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
46
|
Georgin-Lavialle S, Le Saché-de Peufeilhoux L, Martin L, Soucie E, Bruneau J, Barete S, Dubreuil P, Bodemer C, Hermine O, Lhermitte L. Absence of circulating mast cell precursors in paediatric mastocytosis: could it reflect a different pathophysiology between adults and children with mastocytosis? J Eur Acad Dermatol Venereol 2013; 28:967-71. [DOI: 10.1111/jdv.12182] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2013] [Accepted: 04/11/2013] [Indexed: 11/28/2022]
Affiliation(s)
- S. Georgin-Lavialle
- CNRS UMR 8147; Hôpital Necker-Enfants malades; Paris France
- Centre de Référence des Mastocytoses; Faculté de Médecine et AP-HP Necker-Enfants Malades; Paris France
| | - L. Le Saché-de Peufeilhoux
- Service de Dermatologie; Université Paris Descartes; Paris Sorbonne Cité; Faculté de Médecine et AP-HP Necker-Enfants Malades; Paris France
| | - L. Martin
- Service de dermatologie; Université UNAM, hôpital d'Angers; Angers France
| | - E. Soucie
- Inserm; U1068, CRCM,[ Signaling, Hematopoiesis and Mechanism of Oncogenesis]; Institut Paoli-Calmettes, Marseille; Aix-Marseille Univ; CNRS, UMR7258,CRCM; Marseille France
| | - J. Bruneau
- Laboratoire d'anatomopathologie; Université Paris Descartes, Paris Sorbonne Cité, Faculté de Médecine et AP-HP Necker-Enfants Malades; Paris France
- Institut Image; Necker; Paris France
| | - S. Barete
- CNRS UMR 8147; Hôpital Necker-Enfants malades; Paris France
- Centre de Référence des Mastocytoses; Faculté de Médecine et AP-HP Necker-Enfants Malades; Paris France
| | - P. Dubreuil
- Centre de Référence des Mastocytoses; Faculté de Médecine et AP-HP Necker-Enfants Malades; Paris France
- Inserm; U1068, CRCM,[ Signaling, Hematopoiesis and Mechanism of Oncogenesis]; Institut Paoli-Calmettes, Marseille; Aix-Marseille Univ; CNRS, UMR7258,CRCM; Marseille France
| | - C. Bodemer
- Centre de Référence des Mastocytoses; Faculté de Médecine et AP-HP Necker-Enfants Malades; Paris France
- Service de Dermatologie; Université Paris Descartes; Paris Sorbonne Cité; Faculté de Médecine et AP-HP Necker-Enfants Malades; Paris France
- Institut Image; Necker; Paris France
| | - O. Hermine
- CNRS UMR 8147; Hôpital Necker-Enfants malades; Paris France
- Centre de Référence des Mastocytoses; Faculté de Médecine et AP-HP Necker-Enfants Malades; Paris France
- Service d'Hématologie Adultes; Université Paris Descartes, Paris Sorbonne Cité, Faculté de Médecine et AP-HP Necker-Enfants Malades; Paris France
- Institut Image; Necker; Paris France
| | - L. Lhermitte
- CNRS UMR 8147; Hôpital Necker-Enfants malades; Paris France
- Laboratoire d'hématologie Biologique et UMR CNRS 8147; Université Paris Descartes, Paris Sorbonne Cité, Faculté de Médecine et AP-HP Necker-Enfants Malades; Paris France
| |
Collapse
|
47
|
Cohen Aubart F, Arnaud L, Hervier B, Besnard S, Barete S, Graffin B, Lifermann F, Ory JP, Hoang Xuan K, Benameur N, Amoura Z, Haroche J. Efficacité à moyen terme du vémurafénib dans la maladie d’Erdheim–Chester. Rev Med Interne 2013. [DOI: 10.1016/j.revmed.2013.03.321] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
48
|
Demongeot-Caraux C, Soria A, Barete S, Francès C. Le syndrome H, un diagnostic à ne pas méconnaître. Ann Dermatol Venereol 2013. [DOI: 10.1016/j.annder.2013.01.403] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
49
|
Bulai Livideanu C, Tournier E, Laurent C, Sans B, Laroche M, Lamant L, Chandesris MO, Barete S, Hermine O, Laurent G, Paul C. Évaluation de l’atteinte cutanée mastocytaire sous Interféron alpha. Ann Dermatol Venereol 2012. [DOI: 10.1016/j.annder.2012.10.524] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
50
|
Lafont E, Lhermitte L, Chandesris M, Hirsch I, Guichard I, Durieu I, Rétornaz F, Hamidou M, Barete S, Lortholary O, Hermine O, Georgin-Lavialle S. Flushs sans urticaire pigmentaire au cours de la mastocytose systémique : étude de 9 cas. Rev Med Interne 2012. [DOI: 10.1016/j.revmed.2012.10.083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|